The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update

Por Silverman, LR, Fenaux, P, Mufti, GJ, Santini, V, Hellström-Lindberg, E, Gattermann, N, Sanz, G, List, AF, Gore, SD, Seymour, JF, Backstrom, J, McKenzie, D, Beach, CL
Publicado em 2008